Table 3.
Unadjusted and Adjusted Odds of Having CKD by Combinations of Components of MetS Among the Study Population in Viçosa, Minas Gerais, in 2018
| CKD | ||||||
|---|---|---|---|---|---|---|
| Not adjusted | Adjusted by Sex and Age | Multivariate Adjustmentª | ||||
| OR (95% CI) | p-value b | OR (95% CI) | p-value b | OR (95% CI) | p-value b | |
| HBP+AO+LHDL | 1.74 (1.17–2.59) | 0.006 | 1.90 (1.23–2.93) | 0.004 | 1.80 (1.14–2.85) | 0.012* |
| HBP+AO+HTGL | 1.44 (0.96–2.16) | 0.081 | 1.45 (0.94–2.25) | 0.092 | 1.56 (0.98–2.48) | 0.062 |
| HBP+AO+HFBG | 2.36 (1.58–3.52) | 0.000 | 2.48 (1.62–3.77) | 0.000 | 2.67 (1.70–4.20) | 0.000* |
| HBP+LHDL+HTGL | 1.33 (0.91–1.94) | 0.141 | 1.20 (0.82–1.77) | 0.352 | 1.30 (0.85–1.97) | 0.235 |
| HBP+LHDL+HFBG | 2.20 (1.50–3.22) | 0.000 | 2.03 (1.37–2.99) | 0.000 | 2.31 (1.51–3.53) | 0.000* |
| AO+LHDL+HTGL | 1.72 (1.17–2.54) | 0.006 | 1.58 (1.07–2.35) | 0.022 | 1.82 (1.18–2.80) | 0.006* |
| AO+HFBG+HTGL | 1.52 (1.00–2.31) | 0.049 | 1.55 (0.99–2.43) | 0.054 | 1.55 (0.96–2.49) | 0.072 |
| AO+LHDL+HFBG | 2.48 (1.63–3.76) | 0.000 | 2.58 (1.65–4.01) | 0.000 | 2.49 (1.55–4.00) | 0.000* |
| LHDL+HTGL+HFBG | 2.17 (1.41–3.35) | 0.000 | 2.24 (1.42–3.52) | 0.000 | 2.34 (1.43–3.82) | 0.001* |
| HBP+HTGL+HFBG | 1.80 (1.21–2.67) | 0.004 | 1.65 (1.11–2.47) | 0.014 | 1.78 (1.15–2.75) | 0.010* |
| HBP+HTGL+AO+LHDL | 1.48 (0.97–2.26) | 0.069 | 1.48 (0.94–2.32) | 0.089 | 1.52 (0.94–2.44) | 0.087 |
| HBP+HTGL+HFBG+LHDL | 1.87 (1.25–2.80) | 0.002 | 1.69 (1.13–2.54) | 0.011 | 1.86 (1.20–2.89) | 0.006* |
| HBP+HTGL+HFBG+AO | 2.14 (1.38–3.33) | 0.001 | 2.16 (1.37–3.42) | 0.001 | 2.31 (1.41–3.78) | 0.001* |
| HBP+LHDL+HFBG+AO | 2.50 (1.63–3.82) | 0.000 | 2.53 (1.62–3.96) | 0.000 | 2.50 (1.55–4.02) | 0.000* |
| HTGL+LHDL+HFBG+AO | 2.26 (1.44–3.53) | 0.000 | 2.31 (1.45–3.68) | 0.000 | 2.31 (1.40–3.81) | 0.001* |
Notes: ªAdjusted for age, sex, smoking, serum albumin and serum calcium; bp-values calculated by logistic regression; *statistically significant values. Abdominal obesity, defined by a waist circumference ≥102 cm in men and ≥88 cm in women; high blood pressure, defined as systolic blood pressure ≥130 mmHg, or diastolic blood pressure ≥85 mmHg, medical diagnosis and/or use of antihypertensive drugs; elevated plasma triglycerides (≥150 mg/dL) or treated dyslipidemia; low fasting HDL cholesterol (men <40 mg/dL and women <50 mg/dL) and high fasting blood glucose (≥100 mg/dL) or use of antidiabetic medication. Metabolic syndrome defined as having three or more of the following components: abdominal obesity, high blood pressure, elevated fasting blood glucose, high triglycerides and low HDL cholesterol.
Abbreviations: OR, odds ratio; CI, confidence interval; HBP, high blood pressure; BHDL, low-density lipoprotein cholesterol; OA, abdominal obesity; HTGL, high triglycerides; HFBG, high fasting blood glucose.